4-(5-Bromopyrimidin-2-yl)morpholine,
84539-22-0,
5-Bromo-2-morpholin-1-yl-pyrimidine,
4-(5-Bromo-pyrimidin-2-yl)-morpholine,
5-BROMO-2-(4-MORPHOLINO)PYRIMIDINE,
MORPHOLINE, 4-(5-BROMO-2-PYRIMIDINYL)-,
4-(5-Bromopyrimidin-2-yl)morpholine, 97%,
AC1NOUBI,
ACMC-209pvb,
2-Morpholino-5-bromopyrimidine,
5-Bromo-2-morpholinopyrimidine,
SCHEMBL1873066,
CTK5F2584,
DTXSID40408748,
CEXBOCXKAGPRHD-UHFFFAOYSA-N,
HMS1625O04,
ALBB-019386,
KS-00002AL8,
ZINC1495465,
5-Bromo-2-morpholin-1-ylpyrimidine,
5-Bromo-2-morpholin-4-ylpyrimidine,
ANW-37797,
B2455G,
MFCD00483251,
SBB054510,
4-(5-bromo-2-pyrimidinyl)morpholine,
AKOS000266359,
5-Bromo-2-(morpholin-4-yl)pyrimidine,
AB06306,
AM87231,
CCG-131441,
MCULE-1718016885,
PS-6072,
QC-4096,
RP09157,
Morpholine,4-(5-bromo-2-pyrimidinyl)-,
AJ-26388,
EN000285,
HC210489,
AB0042975,
DB-013576,
FT-0685341,
ST24042985,
ST50949813,
Z0874,
B-5072,
5-Bromo-2-(4-morpholino)pyrimidine, AldrichCPR,
5-bromo-2-morpholin-1-yl-pyrimidine, AldrichCPR,
I03-757,
SR-01000095816,
J-516981,
SR-01000095816-1,
C8H10BrN3O,
5-bromo-2-morpholin-4-yl-pyrimidine,
ACN-030224,
CID5144362,